These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 7755644)
1. Effect of gemfibrozil on the concentration and composition of very low density and low density lipoprotein subfractions in hypertriglyceridemic patients. Dachet C; Cavallero E; Martin C; Girardot G; Jacotot B Atherosclerosis; 1995 Feb; 113(1):1-9. PubMed ID: 7755644 [TBL] [Abstract][Full Text] [Related]
2. The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia. Stalenhoef AF; de Graaf J; Wittekoek ME; Bredie SJ; Demacker PN; Kastelein JJ Atherosclerosis; 2000 Nov; 153(1):129-38. PubMed ID: 11058707 [TBL] [Abstract][Full Text] [Related]
3. Effects of gemfibrozil on very-low-density lipoprotein composition and low-density lipoprotein size in patients with hypertriglyceridemia or combined hyperlipidemia. Yang CY; Gu ZW; Xie YH; Valentinova NV; Yang M; Yeshurun D; Quion JA; Gotto AM Atherosclerosis; 1996 Sep; 126(1):105-16. PubMed ID: 8879439 [TBL] [Abstract][Full Text] [Related]
4. Very low density and low density lipoprotein subfractions in type III and type IV hyperlipoproteinemia. Chemical and physical properties. Packard CJ; Shepherd J; Joerns S; Gotto AM; Taunton OD Biochim Biophys Acta; 1979 Feb; 572(2):269-82. PubMed ID: 218633 [TBL] [Abstract][Full Text] [Related]
5. Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein. Sattar N; Greer IA; Louden J; Lindsay G; McConnell M; Shepherd J; Packard CJ J Clin Endocrinol Metab; 1997 Aug; 82(8):2483-91. PubMed ID: 9253322 [TBL] [Abstract][Full Text] [Related]
6. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase. Chung BH; Segrest JP; Franklin F Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170 [TBL] [Abstract][Full Text] [Related]
7. Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriglyceridemic subjects. Normalization after clofibrate treatment. de Graaf J; Hendriks JC; Demacker PN; Stalenhoef AF Arterioscler Thromb; 1993 May; 13(5):712-9. PubMed ID: 8485123 [TBL] [Abstract][Full Text] [Related]
8. Changes of lipoprotein profile in familial dysbetalipoproteinemia with gemfibrozil. Zhao SP; Smelt AH; Leuven JA; Vroom TF; van der Laarse A; van 't Hooft FM Am J Med; 1994 Jan; 96(1):49-56. PubMed ID: 8304363 [TBL] [Abstract][Full Text] [Related]
9. High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects. Ballantyne FC; Clark RS; Simpson HS; Ballantyne D Metabolism; 1982 May; 31(5):433-7. PubMed ID: 6952064 [TBL] [Abstract][Full Text] [Related]
10. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability. Bredie SJ; de Bruin TW; Demacker PN; Kastelein JJ; Stalenhoef AF Am J Cardiol; 1995 Feb; 75(5):348-53. PubMed ID: 7856526 [TBL] [Abstract][Full Text] [Related]
11. Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment. Eisenberg S; Gavish D; Oschry Y; Fainaru M; Deckelbaum RJ J Clin Invest; 1984 Aug; 74(2):470-82. PubMed ID: 6378975 [TBL] [Abstract][Full Text] [Related]
12. The efficacy of gemfibrozil therapy for raising high density lipoprotein levels. Weis S; Kudchodkar BJ; Clearfield MB; Lacko AG Artery; 1992; 19(6):353-66. PubMed ID: 1471924 [TBL] [Abstract][Full Text] [Related]
13. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia. Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H Artery; 1993; 20(1):1-18. PubMed ID: 8447724 [TBL] [Abstract][Full Text] [Related]
14. Serum lipoproteins, apolipoproteins and very low density lipoprotein subfractions during 6-month fibrate treatment in primary hypertriglyceridaemia. Pauciullo P; Marotta G; Rubba P; Cortese C; Caruso MG; Gnasso A; Fischetti A; Motti C; Mancini M J Intern Med; 1990 Nov; 228(5):425-30. PubMed ID: 2254711 [TBL] [Abstract][Full Text] [Related]
15. Lipoprotein changes in children after liver transplantation: mild hypertriglyceridemia and a decrease in HDL3/HDL2 ratio. Granot E Hepatology; 1998 Jan; 27(1):175-80. PubMed ID: 9425934 [TBL] [Abstract][Full Text] [Related]
16. Changes in composition and distribution of LDL subspecies in hypertriglyceridemic and hypercholesterolemic patients during gemfibrozil therapy. Yuan J; Tsai MY; Hunninghake DB Atherosclerosis; 1994 Sep; 110(1):1-11. PubMed ID: 7857363 [TBL] [Abstract][Full Text] [Related]
17. Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia. Durrington PN; Mackness MI; Bhatnagar D; Julier K; Prais H; Arrol S; Morgan J; Wood GN Atherosclerosis; 1998 May; 138(1):217-25. PubMed ID: 9678787 [TBL] [Abstract][Full Text] [Related]
18. Effect of gemfibrozil on high density lipoprotein subspecies in non-insulin dependent diabetes mellitus. Relations to lipolytic enzymes and to the cholesteryl ester transfer protein activity. Kahri J; Vuorinen-Markkola H; Tilly-Kiesi M; Lahdenperä S; Taskinen MR Atherosclerosis; 1993 Aug; 102(1):79-89. PubMed ID: 8257455 [TBL] [Abstract][Full Text] [Related]
19. Postprandial lipoprotein responses in hypertriglyceridemic subjects with and without cardiovascular disease. Hughes TA; Elam MB; Applegate WB; Bond MG; Hughes SM; Wang X; Tolley EA; Bittle JB; Stentz FB; Kang ES Metabolism; 1995 Aug; 44(8):1082-98. PubMed ID: 7637651 [TBL] [Abstract][Full Text] [Related]
20. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E. Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]